US Stock MarketDetailed Quotes

ABCL AbCellera Biologics

Watchlist
  • 3.270
  • +0.130+4.14%
Close Feb 14 16:00 ET
  • 3.300
  • +0.030+0.91%
Post 20:01 ET
965.85MMarket Cap-5.36P/E (TTM)

AbCellera Biologics Key Stats

AbCellera Biologics Q4 2024 Estimates Date

Currency:USDFeb 27, 2025

Estimate YoY
Revenue
7.58M
-17.62%
EPS
-0.15
+8.57%
Buy

Feb 14, 2025

AbCellera Biologics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 13.969M--
Feb 27, 20252024/Q4-- / 7.579M--
Nov 4, 20242024/Q36.507M / 8.015M--
Aug 6, 20242024/Q27.323M / 10.015M--
May 7, 20242024/Q19.954M / 11.005M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 13.969M--
Feb 27, 20252024/Q4-- / 7.579M--
Nov 4, 20242024/Q36.507M / 8.015M--
Aug 6, 20242024/Q27.323M / 10.015M--
May 7, 20242024/Q19.954M / 11.005M--

Unlock Free Earnings Estimates

AbCellera Biologics Earnings Reports

Read more

Trending Stocks

Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More